Enterprise Healthcare SaaS Sales Leader

TailorMed; New York (NY); On-site; USD 150,000 - 240,000; Full time

Benefits offered by this job

Salary + equity

Premium benefits package

401(k) match

Paid holidays and time off

Parental leave

MacBook and work equipment

Job summary

TailorMed is seeking a Director of Sales to drive growth across health systems, IDNs, oncology networks, and specialty pharmacies. You will own a portfolio of enterprise accounts and lead negotiations, with travel 30–50%.

The role focuses on expanding our digital health, patient access, and affordability solutions. You will thrive in a purpose-driven environment, managing complex healthcare organizations and exceeding quotas in long-cycle sales environments while shaping the future of patient

Qualifications

• Demonstrated success in enterprise-level, B2B healthcare SaaS sales with long cycles and cross-functional stakeholders.
• Experience selling into health systems, IDNs, oncology networks, and specialty pharmacies.
• Understanding of patient affordability landscape and related programs.
• Exceptional communication, presentation, and negotiation skills.

Responsibilities

• Identify and cultivate new sales opportunities and convert relationships into long-term partnerships.
• Develop business plans to achieve and exceed sales targets and quotas.
• Engage clients to understand project scope, budgets, and timelines.
• Own the entire sales cycle from prospecting to closing the deal.

Skills

Enterprise healthcare SaaS sales

Long sales cycles

Cross-functional stakeholder

Portfolio/account management

Relationship building

Job description

TailorMed is seeking a Director of Sales to drive growth across health systems, IDNs, oncology networks, and specialty pharmacies. You will own a portfolio of enterprise accounts and lead negotiations, with travel 30–50%.

The role focuses on expanding our digital health, patient access, and affordability solutions. You will thrive in a purpose-driven environment, managing complex healthcare organizations and exceeding quotas in long-cycle sales environments while shaping the future of patient